Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    3.00 (1.62%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £99.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Director/PDMR Shareholding

30 Mar 2022 07:00

RNS Number : 4700G
Somero Enterprises Inc.
30 March 2022
 

Somero Enterprises Inc.

 

("Somero" or the "Company")

 

Director/PDMR Shareholding

 

Somero announces that on 29 March 2022 it was notified that Howard Hohmann, Director of the Company, sold 30,000 ordinary shares in the Company at an average price of 490.12 pence per share.

As a result of the above transaction, Mr. Hohmann's beneficial interest in Somero is now 43,662 ordinary shares, or 0.08% of Somero's total issued share capital.

For further information, please contact:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, President

Enzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Kate Bannatyne (Corporate Finance)

Tim Redfern (Corporate Broking)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

David Ison +44 (0) 2034 050 205

Sam Modlin

Rebecca Sanders-Hewett

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Howard Hohmann

2.

Reason for the Notification

a)

Position/status

EVP Sales

b)

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Somero Enterprises Inc.

b)

LEI

549300OQ2P18NRWBIW58

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of $0.001 each ("Ordinary Shares")

Identification code

SOM

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

 

Date(s)

Price(s)

Volume(s)

28 March 2022

493.07p

17,500

29 March 2022

486.00p

12,500

 

d)

Aggregated information:

- Aggregated volume

- Price

n/a

30,000

490.12p

e)

Date of the transaction

See above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFAVTIAFIF
Date   Source Headline
16th Apr 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSTransaction in Own Shares and RSUs
15th Mar 20213:50 pmRNSTransaction in Own Shares and RSUs
11th Mar 20215:00 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFinal Results
5th Mar 20215:00 pmRNSHolding(s) in Company
1st Mar 20212:50 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update
15th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Nov 20207:00 amRNSTrading Statement
13th Nov 20204:22 pmRNSHolding(s) in Company
11th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 20203:49 pmRNSTransactions in Own Shares
22nd Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Sep 20209:05 amRNSSecond Price Monitoring Extn
9th Sep 20209:00 amRNSPrice Monitoring Extension
9th Sep 20207:00 amRNSInterim Results
13th Aug 20205:22 pmRNSHolding(s) in Company
4th Aug 20201:53 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSTrading Update
23rd Jun 20201:54 pmRNSHolding(s) in Company
10th Jun 20207:00 amRNSResult of AGM
8th Jun 20207:00 amRNSAGM Statement
5th Jun 20207:00 amRNSCOVID-19 Update
26th May 20207:00 amRNSAnnual Report Correction - Replacement
22nd May 20205:30 pmRNSAnnual Report Correction
16th Apr 20207:00 amRNSAnnual Report, AGM Notice & QCA CG Code Adoption
30th Mar 20207:00 amRNSCOVID-19 Update
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20209:00 amRNSPrice Monitoring Extension
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSTransactions in Own Shares and RSUs
16th Mar 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.